Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Rutten

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Portfolio theory and cost-effectiveness analysis: a further discussionPedram Sendi, Maiwenn J Al, Frans F H Rutten
Pharmacoeconomics|July 3, 2002
Standardisation of costs: the Dutch Manual for Costing in economic evaluationsJan B Oostenbrink, Marc A Koopmanschap, Frans F H Rutten
Nederlands Tijdschrift Voor Geneeskunde|December 1, 2004
[Summary of the practice guideline 'Stable angina pectoris' (second revision) from the Dutch College of General Practitioners]M Bouma, F H Rutten, A M Bohnen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese peopleCarmen Galani, Maiwenn Al, Heinz Schneider, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 9, 2004
[The practice guideline 'Stable angina pectoris' (second revision) from the Dutch College of General Practitioners; a response from the perspective of cardiology]M Bouma, F H Rutten, A M Bohnen, et al.
Health Economics|January 11, 2008
Costs and prices of single dental fillings in Europe: a micro-costing studySiok Swan Tan, W Ken Redekop, Frans F H Rutten
The International Journal of Health Planning and Management|December 13, 2005
Regulating the Dutch pharmaceutical market: improving efficiency or controlling costs?Peter de Wolf, Werner B F Brouwer, Frans F H Rutten
Journal of Evaluation in Clinical Practice|November 3, 2010
Incorporation of economic evidence in the Dutch guideline 'cardiovascular risk management'Siok Swan Tan, Frans F H Rutten, Leona Hakkaart-van Roijen
Nederlands Tijdschrift Voor Geneeskunde|January 26, 2011
[New drugs: money-back guarantee?]Adri Steenhoek, Marc A Koopmanschap, Margreet G Franken, et al.
International Journal of Cardiology|August 30, 2000
Electrocardiography in primary care; is it useful?F H Rutten, A G Kessels, F F Willems, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Portfolio theory and cost-effectiveness analysis: a further discussionPedram Sendi, Maiwenn J Al, Frans F H Rutten
Pharmacoeconomics|July 3, 2002
Standardisation of costs: the Dutch Manual for Costing in economic evaluationsJan B Oostenbrink, Marc A Koopmanschap, Frans F H Rutten
Nederlands Tijdschrift Voor Geneeskunde|December 1, 2004
[Summary of the practice guideline 'Stable angina pectoris' (second revision) from the Dutch College of General Practitioners]M Bouma, F H Rutten, A M Bohnen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese peopleCarmen Galani, Maiwenn Al, Heinz Schneider, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 9, 2004
[The practice guideline 'Stable angina pectoris' (second revision) from the Dutch College of General Practitioners; a response from the perspective of cardiology]M Bouma, F H Rutten, A M Bohnen, et al.
Health Economics|January 11, 2008
Costs and prices of single dental fillings in Europe: a micro-costing studySiok Swan Tan, W Ken Redekop, Frans F H Rutten
The International Journal of Health Planning and Management|December 13, 2005
Regulating the Dutch pharmaceutical market: improving efficiency or controlling costs?Peter de Wolf, Werner B F Brouwer, Frans F H Rutten
Journal of Evaluation in Clinical Practice|November 3, 2010
Incorporation of economic evidence in the Dutch guideline 'cardiovascular risk management'Siok Swan Tan, Frans F H Rutten, Leona Hakkaart-van Roijen
Nederlands Tijdschrift Voor Geneeskunde|January 26, 2011
[New drugs: money-back guarantee?]Adri Steenhoek, Marc A Koopmanschap, Margreet G Franken, et al.
International Journal of Cardiology|August 30, 2000
Electrocardiography in primary care; is it useful?F H Rutten, A G Kessels, F F Willems, et al.
Pageof 8